The present invention relates to a new composition comprising ubidecarenone with improved bioavailability for use in softgel capsules. The compositions can be used as a medicine, a food or food supplement. The invention further relates to compositions comprising different fats or oils that facilitate the manufacture and stability of crystallized ubidecarenone.